Elysium Health
PrivateLast Round
Series C
Dec 23, 2019
Est. Valuation
$157M
Total Funding Raised
$80M
Company Overview
Elysium Health is a life sciences company that develops and sells clinically validated health products and supplements based on scientific research in aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, E-commerce, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elysium Health Comparables
Compare Elysium Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qualia Life Sciences | 86% | |
| Niagen Bioscience, Inc. | 85% | |
| NOVOS | 83% | |
Elysium Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 23, 2019 | ||||
| Debt | Jun 29, 2017 | ||||
| Series B | Dec 6, 2016 | ||||
| Seed | Feb 1, 2014 |
Elysium Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series C |
| Breyer Capital | Series C, Series B |
| Greylock Partners | Series A |
| Morningside Ventures | Series A, Series C, Series B |
| General Catalyst | Series C, Series B |
| Mayo Clinic Ventures | Series C |
| Sound Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2025
Launched COFACTOR, a 4-in-1 collagen and NAD+ system.
- Dec 23, 2019
Raised $40M led by GISEV.
Elysium Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elysium Health's valuation, stock price, and market status.